Inspiring the Next Generation: Engaging Your Students in Sciences and STEM Careers through Genetics

Barbara Kraatz Fortini, Associate Professor of Genetics is currently Director of the Center for Training in Applied Genomics at KGI, and serves as the Program Director for >span class="NormalTextRun SCXW63644289 BCX0" data-ccp-parastyle="Normal (Web)"> Master of Science in Human Genetics and Genomic Data Analytics (MSGDA), an execute-education Certificate in Applied Genomics (CAG), and the Clinical Genetics and Bioinformatics (CGB) summer program for undergraduates.   Within the KGI curriculum, Fortini teaches courses in Human Molecular Genetics, Human Genomics, and Functional Genomics. Fortini’s research is focused on how non-coding genomic variation affects colorectal cancer risk, using both bioinformatics and cell-based assays to understand the consequences of variants associated with colon cancer.  Fortini completed her postdoctoral training at the Keck School of Medicine of USC in the Department of Preventive Medicine at the USC Norris Comprehensive Cancer Center. She received her BS in 2002 and her PhD in 2011 at the California Institute of Technology.

Dr. Williamson graduated from the University of Rochester (UR) with a major in biochemistry and minors in chemistry and American Sign Language in 1998. She then earned her PhD in genetics from Harvard University in 2005. She served as Deputy Editor of the American Journal of Human Genetics from 2005 to 2011. She then worked as a subject matter expert and project manager for the consultant firm Booz Allen Hamilton and supported clients who funded military health research. In 2014 Dr. Williamson worked for a personalized cancer genetics company, and in 2016 she returned to UR where she was a research project manager for a lab working towards developing stem cell derivatives to treat multiple sclerosis. In 2018 she earned her Master's in secondary science education at the Warner School of Education, and she now teaches 7th grade science at Gates Chili Middle School near Rochester, NY.

Sara C. Zapico is an assistant professor in the Department of Chemistry and Environmental Sciences at New Jersey Institute of Technology. She is also a research collaborator at the Smithsonian Institution. She received her PhD in biochemistry, with a focus in biomedical sciences, from the University of Oviedo in Spain, and her Master's in forensic Anthropology and Genetics from the University of Granada, in Spain. After that, she was a postdoctoral fellow at Smithsonian Institution and an associate at the forensic unit from the International Committee of the Red Cross in Geneva, Switzerland, completing her postdoctoral training with other visiting scientist positions. Her research interests focus on the application of biochemical techniques to forensic science issues, like age-at-death estimation and the determination of post-mortem interval, with implications in aging and biomedical research. 

Kenneth S. Ramos, MD, PhD is an accomplished physician-scientist with designations in the National Academy of Medicine and National Academy of Sciences. He is a transformational leader recognized throughout the world for his scientific contributions in the areas of genomics, precision medicine and toxicology.

With formal training in pharmaceutical sciences, chemistry, biochemistry, pharmacology, and medicine, Dr. Ramos is helping to steer the changing landscape of medicine, biotechnology and healthcare. In this context, he leads several translational, clinical research, and educational programs that integrate diverse approaches to elucidate genomic mechanisms of disease and to develop novel therapies for several oncologic, pulmonary, and vascular diseases.  

Dr. Ramos has provided academic, executive, administrative, and scientific leadership in the areas of genetics and genomic medicine and toxicology at various academic institutions and over the course of his career has positively influenced the career of numerous clinicians and scientists engaged in medical, veterinary and pharmaceutical practice. He is deeply committed to initiatives that advance modern technological applications to improve quality of healthcare and reduce disease burden and health-associated costs.